Arnab Basu, MD, MPH, FACP, is an academic genitourinary oncologist focusing in the care of patients with kidney cancer and bladder cancer at the University of Alabama.
Basu Provides an Overview of MRD GATE RCC
Arnab Basu, MD, MPH, FACP, discusses molecular residual disease-guided adjuvant therapy in patients with renal cell carcinoma, highlighting the rationale and goals of the MRD gate RCC clinical trial.